High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19. (2nd September 2022)

• Record Type: Journal Article
• Authors: Ripa, Marco; Galli, Laura; D'Angelo, Armando; Apruzzi, Luca; Palumbo, Diego; Campochiaro, Corrado; Tassan Din, Chiara; Danise, Anna; Da Prat, Valentina; Vitali, Giordano; Brugliera, Luigia; Poli, Andrea; Monardo, Roberta; Monti, Giacomo; Baccellieri, Domenico; De Cobelli, Francesco; Clementi, Massimo; Iannaccone, Sandro; Dagna, Lorenzo; Rovere-Querini, Patrizia; Ciceri, Fabio; Tresoldi, Moreno; Zangrillo, Alberto; Scarpellini, Paolo; Castagna, Antonella
• Is Part Of: Open forum infectious diseases. Volume 9:Number 9(2022)
• Publication Date: 2022-09-02
• Subjects: thrombosis -- bacteria -- coronavirus -- infections -- pulmonary embolism; Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofac454
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: Background: This study's primary aim was to evaluate the impact of thrombotic complications on the development of secondary infections. The secondary aim was to compare the etiology of secondary infections in patients with and without thrombotic complications. Methods: This was a cohort study (NCT04318366) of coronavirus disease 2019 (COVID-19) patients hospitalized at IRCCS San Raffaele Hospital between February 25 and June 30, 2020. Incidence rates (IRs) were calculated by univariable Poisson regression as the number of cases per 1000 person-days of follow-up (PDFU) with 95% confidence intervals. The cumulative incidence functions of secondary infections according to thrombotic complications were compared with Gray's method accounting for competing risk of death. A multivariable Fine-Gray model was applied to assess factors associated with risk of secondary infections. Results: Overall, 109/904 patients had 176 secondary infections (IR, 10.0; 95% CI, 8.8–11.5; per 1000-PDFU). The IRs of secondary infections among patients with or without thrombotic complications were 15.0 (95% CI, 10.7–21.0) and 9.3 (95% CI, 7.9–11.0) per 1000-PDFU, respectively ( P = .017). At multivariable analysis, thrombotic complications were associated with the development of secondary infections (subdistribution hazard ratio, 1.788; 95% CI, 1.018–3.140; P = .043). The etiology of secondary infections was similar in patients with and without thrombotic complications. Conclusions: In patients with COVID-19, thrombotic complications were associated with a high risk of secondary infections.